Transgene Announces Completion of Enrollment in TRAVERSE, a Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer
Transgene Announces Completion of Enrollment in TRAVERSE, a Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer
Regulatory News :
Novo A/S acquires Xellia Pharmaceuticals for US$ 700 million
Biogen Idec Submits Application to FDA for Approval of PLEGRIDY™ (Peginterferon Beta-1a) in Multiple Sclerosis
— EMA Submission Planned in the Coming Weeks —
Biogen Idec Submits Application to FDA for Approval of PLEGRIDY™ (Peginterferon Beta-1a) in Multiple Sclerosis
From Research Labs to Doctors' Offices, Health Care Providers at Lilly Play Important Role in Bringing New and Innovative Medicines to Patients
Video shows how those from the medical field bring patient care experience to pharmaceutical career
INDIANAPOLIS,
Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS)
Symptom improvements in-line with effects reported with stimulant drugs
LOS ANGELES, May 20, 2013 /P
UK calls for international action on antimicrobial resistance
Novartis drug Afinitor® significantly extended time without disease progression in women with HER2 positive advanced breast cancer
CytRx Issues Letter to Stockholders Providing Business Update
- Provides Detailed Roadmap for Oncology Drug Development Programs -
CytRx Issues Letter to Stockholders Providing Business Update
Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company
Acorda Therapeutics Announces Issuance of Additional U.S. Patent for AMPYRA® Covering a Range of Dosage Strengths
<0> Acorda TherapeuticsJeff Macdonald, 914-326-5232 </0>
Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company
Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech
SAN JOSE, Calif., May 17, 2013 /PRNewswire-iReach/ -- Aridis is pleased to announce that an agreement has bee
Mylan Launches Generic Tricor® Tablets
Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
THOUSAND OAKS, Calif., May 15, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will pre
New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal Cancer
Biomarker Analysis From Phase 3 PRIME ('203) Study and Phase 2 PEAK ('509) Study Link Additional RAS Gene Mutations to Vectibix Clinical Response
Bayer to Present New Data Across Oncology Portfolio at ASCO 2013
WAYNE, N.J., May 15, 2013 /PRNewswire/ -- Intended for U.S.
Foundation Medicine to Present Clinical Data on its FoundationOne™ Cancer Genomic Profile at the 2013 ASCO Annual Meeting
<0> Pure Communications, Inc.Dan Budwick, 973-271-6085 </0>
FDA approves Simponi to treat ulcerative colitis
Navidea Biopharmaceuticals Signs Manufacturing and Supply Agreement with Nordion
<0> Navidea BiopharmaceuticalsBrent Larson, CFO, 614-822-2330orInvestor RelationsStern Investor Relations, Inc.Beth DelGiacco, 212-362-1200 </0>
